Evidence map›Paper›PMID 39074471›Full record

ArticleIntegrative biology : quantitative biosciences from nano to macro2024

Probing T-cell activation in nanoliter tumor co-cultures using membrane displacement trap arrays.

Michael Yeh, Emanuel Salazar-Cavazos, Anagha Krishnan, Grégoire Altan-Bonnet, Don L DeVoe

Abstract read
In one paragraph

Article in Integrative biology : quantitative biosciences from nano to macro, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michael YehDepartment of Mechanical Engineering, University of Maryland, College Park, MD 20742, United States.
Emanuel Salazar-CavazosNational Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States.
Anagha KrishnanNational Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States.
Grégoire Altan-BonnetNational Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States.
Don L DeVoeDepartment of Mechanical Engineering, University of Maryland, College Park, MD 20742, United States.ORCID 0000-0002-7740-9993

Funding

Phenotypic variability within isogenic population of lymphocytesZIABC011726 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ALTAN-BONNET, GRÉGOIRE · 2016 to 2025
$3.9M
A rapid, automated system for bacteria profiling of intra-abdominal infectionsR01AI153564 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI DEVOE, DON L, WHITE, IAN M · 2021 to 2025
$2.7M
NIAID NIH HHS R01 AI153564NIH HHS R01AI153564
6 · The paper itself

Abstract

Immune responses against cancer are inherently stochastic, with small numbers of individual T cells within a larger ensemble of lymphocytes initiating the molecular cascades that lead to tumor cytotoxicity. A potential source of this intra-tumor variability is the differential ability of immune cells to respond to tumor cells. Classical microwell co-cultures of T cells and tumor cells are inadequate for reliably culturing and analyzing low cell numbers needed to probe this variability, and have failed in recapitulating the heterogeneous small domains observed in tumors. Here we leverage a membrane displacement trap array technology that overcomes limitations of conventional microwell plates for immunodynamic studies. The microfluidic platform supports on-demand formation of dense nanowell cultures under continuous perfusion reflecting the tumor microenvironment, with real-time monitoring of T cell proliferation and activation within each nanowell. The system enables selective ejection of cells for profiling by fluorescence activated cell sorting, allowing observed on-chip variability in immune response to be correlated with off-chip quantification of T cell activation. The technology offers new potential for probing the molecular origins of T cell heterogeneity and identifying specific cell phenotypes responsible for initiating and propagating immune cascades within tumors. Insight Box Variability in T cell activation plays a critical role in the immune response against cancer. New tools are needed to unravel the mechanisms that drive successful anti-tumor immune response, and to support the development of novel immunotherapies utilizing rare T cell phenotypes that promote effective immune surveillance. To this end, we present a microfluidic cell culture platform capable of probing differential T cell activation in an array of nanoliter-scale wells coupled with off-chip cell analysis, enabling a high resolution view of variable immune response within tumor / T cell co-cultures containing cell ensembles orders of magnitude smaller than conventional well plate studies.

Indexed as

Coculture TechniquesLymphocyte ActivationT-LymphocytesTumor MicroenvironmentCell Line, TumorCell ProliferationEquipment DesignFlow CytometryHumansLab-On-A-Chip DevicesMicrofluidic Analytical TechniquesNeoplasmsimmunodynamicsmembrane displacement trapsmicrofluidics

Identifiers

PMID39074471
PMCPMC11286267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.